J. Clin. Invest.

ISSN	1558-8238
ISSN-L	0021-9738
IUID	0190ce3f34364bc582b4aa74c158a28e
Modified	2020-11-27T13:12:55.747Z
Created	2018-12-05T09:16:02.703Z

Year 2026

PubMed DOI Crossref

Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers

Paschalis A, Figueiredo I, Bogdan D, ..., Gaughan L, de Bono J

J. Clin. Invest. 136 (7) - [2026-04-01; online 2026-04-01] Open Access

Arian Lundberg DDLS Fellow

Year 2024

PubMed DOI Crossref

Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation.

Bohlen J, Bagarić I, Vatovec T, ..., Casanova JL, Bustamante J

J. Clin. Invest. 134 (20) - [2024-10-15; online 2024-10-15]

PubMed DOI Crossref

IL-7-dependent and -independent lineages of IL-7R-dependent human T cells.

Arango-Franco CA, Ogishi M, Unger S, ..., Casanova JL, Puel A

J. Clin. Invest. 134 (19) - [2024-10-01; online 2024-10-01]

PubMed DOI Crossref

BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.

Westaby D, Jiménez-Vacas JM, Figueiredo I, ..., de Bono J, Sharp A

J. Clin. Invest. 134 (18) - [2024-09-17; online 2024-09-17]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma.

Nagarajan D, Parracho RT, Corujo D, ..., Buschbeck M, Mao Y

J. Clin. Invest. 134 (21) - [2024-09-10; online 2024-09-10]

PubMed DOI Crossref

Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.

Zhu X, Farsh T, Vis D, ..., van der Heijden MS, Feng FY

J. Clin. Invest. 134 (19) - [2024-08-13; online 2024-08-13]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals.

Peel JN, Yang R, Le Voyer T, ..., Ku CL, Casanova JL

J. Clin. Invest. 134 (8) - [2024-03-12; online 2024-03-12]

Year 2023

PubMed DOI Crossref

Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src.

Sjöberg E, Melssen M, Richards M, ..., Dimberg A, Claesson-Welsh L

J. Clin. Invest. 133 (20) - [2023-10-16; online 2023-10-16]

PubMed DOI Crossref

Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.

Yu Z, Fidler TP, Ruan Y, ..., Tall AR, Natarajan P

J. Clin. Invest. 133 (18) - [2023-09-15; online 2023-09-15]

Abhishek Niroula DDLS Fellow

PubMed DOI Crossref

Obesity-induced inflammation exacerbates clonal hematopoiesis.

Pasupuleti SK, Ramdas B, Burns SS, ..., Natarajan P, Kapur R

J. Clin. Invest. 133 (11) - [2023-06-01; online 2023-06-01]

Abhishek Niroula DDLS Fellow

PubMed DOI Crossref

IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy.

Tunalı G, Rúbies Bedós M, Nagarajan D, ..., Papakyriacou I, Mao Y

J. Clin. Invest. 133 (7) - [2023-04-03; online 2023-04-03]

Year 2020

PubMed DOI Crossref

How the matrix metalloproteinase MMP14 contributes to the progression of colorectal cancer.

Claesson-Welsh L

J. Clin. Invest. 130 (3) 1093-1095 [2020-03-02; online 2020-02-06]

Year 2019

PubMed DOI Crossref

Caspase-8 modulates physiological and pathological angiogenesis during retina development.

Tisch N, Freire-Valls A, Yerbes R, ..., Augustin HG, Ruiz de Almodovar C

J. Clin. Invest. 129 (12) 5092-5107 [2019-12-02; online 2019-08-28]

Year 2018

PubMed DOI Crossref

Ca2+-binding protein NECAB2 facilitates inflammatory pain hypersensitivity.

Zhang MD, Su J, Adori C, ..., Harkany T, Hökfelt T

J. Clin. Invest. 128 (9) 3757-3768 [2018-08-31; online 2018-07-30]

PubMed DOI Crossref

CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.

Lugano R, Vemuri K, Yu D, ..., Dejana E, Dimberg A

J. Clin. Invest. 128 (8) 3280-3297 [2018-08-01; online 2018-06-25]

PubMed DOI Crossref

LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.

Yu K, Davidson CL, Wójtowicz A, ..., Swiss Transplant Cohort Study , Burshtyn DN

J. Clin. Invest. 128 (4) 1523-1537 [2018-04-02; online 2018-03-12]

PubMed DOI Crossref

STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells.

Liu Y, Lv J, Liu J, ..., Qin FX, Huang B

J. Clin. Invest. 128 (3) 1057-1073 [2018-03-01; online 2018-02-12]

Affiliated researcher

Year 2017

PubMed DOI Crossref

Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.

Wild PS, Felix JF, Schillert A, ..., Vasan RS, Dörr M

J. Clin. Invest. 127 (5) 1798-1812 [2017-05-01; online 2017-04-10]

Affiliated researcher

Year 2016

PubMed DOI Crossref

TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.

Doorduijn EM, Sluijter M, Querido BJ, ..., van der Burg SH, van Hall T

J. Clin. Invest. 126 (2) 784-794 [2016-02-00; online 2016-01-19]

Year 2015

PubMed DOI Crossref

Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.

Albrecht I, Wick C, Hallgren Å, ..., Kämpe O, Lundberg IE

J. Clin. Invest. 125 (12) 4612-4624 [2015-12-00; online 2015-11-09]

Year 2014

PubMed DOI Crossref

Abolished InsP3R2 function inhibits sweat secretion in both humans and mice.

Klar J, Hisatsune C, Baig SM, ..., Mikoshiba K, Dahl N

J. Clin. Invest. 124 (11) 4773-4780 [2014-11-00; online 2014-10-20]